Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimerʼs Disease - Concepedia

Concepedia

Publication | Closed Access

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimerʼs Disease

31

Citations

14

References

2009

Year

Stephen M. Aronson, B. Van Baelen, Shane Kavanagh, S. Schwalen

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineOptimal DosingNeurochemical BiomarkersPharmacotherapyNeurologyAging-associated DiseasePharmacologyTreatmentModerate Alzheimerʼs Disease

References

	Year	Citations

Page 1